Azelastine HCl Nasal Solution (Nasal Spray) 0.1% (137 mcg per spray), 30 mL, Rx only, Distributed...
FDA Drug Recall #D-0417-2018 — Class III — February 5, 2018
Recall Summary
| Recall Number | D-0417-2018 |
| Classification | Class III — Low risk |
| Date Initiated | February 5, 2018 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Sun Pharmaceutical Industries, Inc. |
| Location | Cranbury, NJ |
| Product Type | Drugs |
| Quantity | 17554 bottles |
Product Description
Azelastine HCl Nasal Solution (Nasal Spray) 0.1% (137 mcg per spray), 30 mL, Rx only, Distributed by: Sun Pharmaceutical Ind. Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Ind. Ltd. Halol-Baroda Highway, Halol - 389 350, Gujarat, India --- NDC 47335-779-91
Reason for Recall
Sun Pharmaceutical is recalling Azelastine HCl Nasal Solution, 0.1% (30 mL Bottle) following a failure to meet the % RSD requirement in the test for Droplet Size during the 6 month long term stability test station
Distribution Pattern
Nationwide
Lot / Code Information
JKR7706A December 2018 JKR7705A November 2018
Other Recalls from Sun Pharmaceutical Industries, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-1032-2020 | Class II | Doxycycline Capsules, USP, 75 mg, 100-count bot... | Mar 13, 2020 |
| D-1033-2020 | Class II | Doxycycline Capsules, USP, 100 mg, 50-count bot... | Mar 13, 2020 |
| D-1047-2020 | Class II | Atorvastatin Calcium Tablets, USP 40 mg, Rx onl... | Mar 9, 2020 |
| D-0788-2020 | Class II | Testosterone Cypionate for Injection, 2,000 mg/... | Jan 14, 2020 |
| D-0787-2020 | Class II | Testosterone Cypionate for Injection, USP, 1,00... | Jan 14, 2020 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.